Locate Palm Springs buprenorphine and suboxone doctors who specialize in the treatment of opioid addiction.
|
Barry Solof, M.D.
2095 North Indian Canyon Drive
Palm Springs, CA 92262
Main Tel: (760) 416-7951
|
|
Dr. Joseph Abraham Mott, M.D.
2095 North Indian Canyon Drive
Palm Springs, CA 92262
Main Tel: (877) 345-8494
|
|
Kenneth Russ, M.D.
490 South Farrell Drive
Suite C-106
Palm Springs, CA 92262
Main Tel: (760) 416-6773
|
|
Dr. Harry David Goldwasser, M.D.
1910 S Camino Real
Palm Springs, CA 92264
Main Tel: (760) 416-7951
|
|
Dr. Edmund Ayoub, Jr., M.D.
3655 East Ramon Road
Palm Springs, CA 92264
Main Tel: (760) 327-9400
|
|
Dr. Nina Khin Maw Maw, M.D
35900 Bob Hope Drive
Unit #230
Rancho Mirage, CA 92270
Main Tel: (760) 324-2800
|
|
Dr. Albert Lai, M.D.
Desert Pain & Rehabilitation Associates
72-780 Country Club Drive #C300
Rancho Mirage, CA 92270
Main Tel: (760) 341-5550
|
|
|
|
Dr. Albert Lai, M.D.
Desert Pain & Rehabilitation Associates
72-780 Country Club Drive #C300
Rancho Mirage, CA 92270
Main Tel: (760) 341-5550
|
|
Dr. Robert Keith Simpson, D.O.
27620 Landau Boulevard
Suite 3
Cathedral City, CA 92240
Main Tel: (888) 867-2280
|
|
Dr. Reham Antoun Youssef Attia, M.D.
Betty Ford Center
39000 Bob Hope Drive
Rancho Mirage, CA 92270
Main Tel: (760) 776-4100
|
|
Dr. Andrew Janik, M.D.
41750 Rancho Las Palmas Drive
Suite C-3
Rancho Mirage, CA 92270
Main Tel: (760) 776-4770
|
|
Dr. Lee Wayne Erlendson, M.D.
39300 Bob Hope Drive
Suite1203, Bannan Building
Rancho Mirage, CA 92270
Main Tel: (760) 773-3075
|
|
Dr. Albert Lai, M.D.
71843 Highway 111
Suite A
Rancho Mirage, CA 92270
Main Tel: (760) 341-5550
|
|
Richard Torban, M.D.
72624 El Paseo
Suite C-1
Palm Desert, CA 92260
Main Tel: (760) 341-8878
|
|
Dr. Craig S. Rosenblum, M.D.
73-950 Alessandro Drive
Suite 2
Palm Desert, CA 92260
Main Tel: (760) 346-5911
|
Sublocade Now Available
Sublocade is a newly released medication alternative for treating opioid addiction. It is a product of Indivior, the pharmaceutical company responsible for Suboxone. Sublocade is a once monthly injection of time-released buprenorphine typically provided to patients who have been receiving buprenorphine for at least (7) days and who are stable on their medication. The injection Read More
Ohio Increases Buprenorphine Access
In 2017, Ohio increased its number of buprenorphine-approved prescribers by 266. This was the result of a $2.3 million dollar Federal grant that provided state-wide training to doctors, nurse practitioners, and physician assistants as reported by Cleveland.com. Historically, Ohio had numerous communities that were underserved with 19 counties having no buprenorphine providers at the beginning Read More
The Drug Treatment Act of 2000 permitted doctors who meet certain training qualifications to prescribe buprenorphine in the treatment of heroin addiction and other opioid addictions. Buprenorphine physicians became able to assist opioid addicted patients in an office setting bypassing the restrictions that typically apply to patients receiving methadone. This treatment method maximized patient convenience and accessibility thus increasing the number of people who could access medication-assisted treatment (MAT) for opioid addiction.
Sublocade is a newly released medication alternative for treating opioid addiction. It is a product of Indivior, the pharmaceutical company responsible for